Marian L. Kruzel
Vorstandsvorsitzender bei PharmaReview, Inc.
Profil
Marian L.
Kruzel is the founder of PharmaReview, Inc. She previously served as Chairman of the Cancer Coalition of America and as Chief Scientific Officer at ReGen Therapeutics Plc.
Aktive Positionen von Marian L. Kruzel
| Unternehmen | Position | Beginn |
|---|---|---|
PharmaReview, Inc.
 PharmaReview, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaReview Corp. develops therapeutics based on recombinant human lactoferrin. Its technology is fully compatible with humans and currently available for preclinical testing. The company was founded by Marian Kruzel and is headquartered in Houston, TX. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Marian L. Kruzel
| Unternehmen | Position | Ende |
|---|---|---|
ReGen Therapeutics Plc
 ReGen Therapeutics Plc Pharmaceuticals: MajorHealth Technology ReGen Therapeutics Plc develops healthcare nutraceutical and ethical pharmaceuticals. Its principal activity is research and development of a drug product called Colostrinin for the treatment for Alzheimer's disease and other neurological disorders. It also involves in the development of Colostrinin peptides as pharmaceutical drug candidates for the treatment of Alzheimer's disease and obesity. ReGen Therapeutics Plc conducts pharmacokinetic and pharmacodynamic research. The company was founded on February 11, 1998 and is headquartered in London, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 23.02.2011 |
Cancer Coalition of America
 Cancer Coalition of America Hospital/Nursing ManagementHealth Services Cancer Coalition of America operated as nonprofit organization. The company was headquartered in Houston, TX. | Vorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
ReGen Therapeutics Plc
ReGen Therapeutics Plc Pharmaceuticals: MajorHealth Technology ReGen Therapeutics Plc develops healthcare nutraceutical and ethical pharmaceuticals. Its principal activity is research and development of a drug product called Colostrinin for the treatment for Alzheimer's disease and other neurological disorders. It also involves in the development of Colostrinin peptides as pharmaceutical drug candidates for the treatment of Alzheimer's disease and obesity. ReGen Therapeutics Plc conducts pharmacokinetic and pharmacodynamic research. The company was founded on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
PharmaReview, Inc.
PharmaReview, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaReview Corp. develops therapeutics based on recombinant human lactoferrin. Its technology is fully compatible with humans and currently available for preclinical testing. The company was founded by Marian Kruzel and is headquartered in Houston, TX. | Commercial Services |
Cancer Coalition of America
Cancer Coalition of America Hospital/Nursing ManagementHealth Services Cancer Coalition of America operated as nonprofit organization. The company was headquartered in Houston, TX. | Health Services |
